Goudgaon NM[au] - Search Results

Year	Number of Results
1991	2
1992	1
1993	1
1994	3
2000	4
2001	1
2009	1
2010	1
2022	0

1

Synthesis and antimicrobial evaluation of 5-iodopyrimidine analogs.

Goudgaon NM, Basha NJ, Patil SB. Goudgaon NM, et al. Indian J Pharm Sci. 2009 Nov;71(6):672-7. doi: 10.4103/0250-474X.59551. Indian J Pharm Sci. 2009. PMID: 20376222 Free PMC article.

2

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase.

el Kouni MH, Goudgaon NM, Rafeeq M, Al Safarjalani ON, Schinazi RF, Naguib FN. el Kouni MH, et al. Among authors: goudgaon nm. Biochem Pharmacol. 2000 Sep 15;60(6):851-6. doi: 10.1016/s0006-2952(00)00410-x. Biochem Pharmacol. 2000. PMID: 10930540

3

Activity of acyclic 6-(phenylselenenyl)pyrimidine nucleosides against human immunodeficiency viruses in primary lymphocytes.

Goudgaon NM, Schinazi RF. Goudgaon NM, et al. J Med Chem. 1991 Nov;34(11):3305-9. doi: 10.1021/jm00115a022. J Med Chem. 1991. PMID: 1720175

4

Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase.

Goudgaon NM, Naguib FN, el Kouni MH, Schinazi RF. Goudgaon NM, et al. J Med Chem. 1993 Dec 24;36(26):4250-4. doi: 10.1021/jm00078a015. J Med Chem. 1993. PMID: 8277507

5

Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase: relevance to chemotherapy.

Ashour OM, Al Safarjalani ON, Naguib FN, Goudgaon NM, Schinazi RF, el Kouni MH. Ashour OM, et al. Among authors: goudgaon nm. Cancer Chemother Pharmacol. 2000;45(5):351-61. doi: 10.1007/s002800051002. Cancer Chemother Pharmacol. 2000. PMID: 10803917

6

Synthesis, in vitro and in vivo antifungal activity of 5-phenylthio-2,4-bisbenzyloxypyrimidine: a novel nucleobase.

Amareshwar V, Patil SJ, Goudgaon NM. Amareshwar V, et al. Among authors: goudgaon nm. Indian J Pharm Sci. 2010 Nov;72(6):778-81. doi: 10.4103/0250-474X.84593. Indian J Pharm Sci. 2010. PMID: 21969752 Free PMC article.

7

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy.

Al Safarjalani ON, Zhou XJ, Naguib FN, Goudgaon NM, Schinazi RF, el Kouni MH. Al Safarjalani ON, et al. Among authors: goudgaon nm. Cancer Chemother Pharmacol. 2001 Aug;48(2):145-50. doi: 10.1007/s002800100292. Cancer Chemother Pharmacol. 2001. PMID: 11565561

8

Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridine.

Schinazi RF, Goudgaon NM, Fulcrand G, el Kattan Y, Lesnikowski Z, Ullas G, Moravek J, Liotta DC. Schinazi RF, et al. Among authors: goudgaon nm. Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1113-20. doi: 10.1016/0360-3016(94)90485-5. Int J Radiat Oncol Biol Phys. 1994. PMID: 8175396

9

Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.

Ashour OM, Naguib FN, Goudgaon NM, Schinazi RF, el Kouni MH. Ashour OM, et al. Among authors: goudgaon nm. Biochem Pharmacol. 2000 Sep 1;60(5):687-92. doi: 10.1016/s0006-2952(00)00375-0. Biochem Pharmacol. 2000. PMID: 10927027

10

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy.

Ashour OM, Naguib FN, Goudgaon NM, Schinazi RF, el Kouni MH. Ashour OM, et al. Among authors: goudgaon nm. Cancer Chemother Pharmacol. 2000;46(3):235-40. doi: 10.1007/s002800000138. Cancer Chemother Pharmacol. 2000. PMID: 11021741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results